Global mRNA Cancer Vaccines and Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global mRNA Cancer Vaccines and Therapeutics market size was valued at USD 144.5 million in 2023 and is forecast to a readjusted size of USD 465.2 million by 2030 with a CAGR of 18.2% during review period.
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
The Global Info Research report includes an overview of the development of the mRNA Cancer Vaccines and Therapeutics industry chain, the market status of Infectious Disease (Adeno Carcinomas, Mucinous Carcinomas), Cancer (Adeno Carcinomas, Mucinous Carcinomas), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of mRNA Cancer Vaccines and Therapeutics.
Regionally, the report analyzes the mRNA Cancer Vaccines and Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global mRNA Cancer Vaccines and Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the mRNA Cancer Vaccines and Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the mRNA Cancer Vaccines and Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Adeno Carcinomas, Mucinous Carcinomas).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the mRNA Cancer Vaccines and Therapeutics market.
Regional Analysis: The report involves examining the mRNA Cancer Vaccines and Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the mRNA Cancer Vaccines and Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to mRNA Cancer Vaccines and Therapeutics:
Company Analysis: Report covers individual mRNA Cancer Vaccines and Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards mRNA Cancer Vaccines and Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infectious Disease, Cancer).
Technology Analysis: Report covers specific technologies relevant to mRNA Cancer Vaccines and Therapeutics. It assesses the current state, advancements, and potential future developments in mRNA Cancer Vaccines and Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the mRNA Cancer Vaccines and Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
mRNA Cancer Vaccines and Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe mRNA Cancer Vaccines and Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of mRNA Cancer Vaccines and Therapeutics, with revenue, gross margin and global market share of mRNA Cancer Vaccines and Therapeutics from 2019 to 2024.
Chapter 3, the mRNA Cancer Vaccines and Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and mRNA Cancer Vaccines and Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of mRNA Cancer Vaccines and Therapeutics.
Chapter 13, to describe mRNA Cancer Vaccines and Therapeutics research findings and conclusion.
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
The Global Info Research report includes an overview of the development of the mRNA Cancer Vaccines and Therapeutics industry chain, the market status of Infectious Disease (Adeno Carcinomas, Mucinous Carcinomas), Cancer (Adeno Carcinomas, Mucinous Carcinomas), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of mRNA Cancer Vaccines and Therapeutics.
Regionally, the report analyzes the mRNA Cancer Vaccines and Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global mRNA Cancer Vaccines and Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the mRNA Cancer Vaccines and Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the mRNA Cancer Vaccines and Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Adeno Carcinomas, Mucinous Carcinomas).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the mRNA Cancer Vaccines and Therapeutics market.
Regional Analysis: The report involves examining the mRNA Cancer Vaccines and Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the mRNA Cancer Vaccines and Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to mRNA Cancer Vaccines and Therapeutics:
Company Analysis: Report covers individual mRNA Cancer Vaccines and Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards mRNA Cancer Vaccines and Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infectious Disease, Cancer).
Technology Analysis: Report covers specific technologies relevant to mRNA Cancer Vaccines and Therapeutics. It assesses the current state, advancements, and potential future developments in mRNA Cancer Vaccines and Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the mRNA Cancer Vaccines and Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
mRNA Cancer Vaccines and Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- Infectious Disease
- Cancer
- Others
- Moderna Therapeutics
- CureVac
- Translate Bio
- BioNTech
- Sangamo Therapeutics
- Argos Therapeutics
- In-Cell-Art
- eTheRNA
- Ethris
- Tiba Biotechnology
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe mRNA Cancer Vaccines and Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of mRNA Cancer Vaccines and Therapeutics, with revenue, gross margin and global market share of mRNA Cancer Vaccines and Therapeutics from 2019 to 2024.
Chapter 3, the mRNA Cancer Vaccines and Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and mRNA Cancer Vaccines and Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of mRNA Cancer Vaccines and Therapeutics.
Chapter 13, to describe mRNA Cancer Vaccines and Therapeutics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of mRNA Cancer Vaccines and Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of mRNA Cancer Vaccines and Therapeutics by Type
1.3.1 Overview: Global mRNA Cancer Vaccines and Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Adeno Carcinomas
1.3.4 Mucinous Carcinomas
1.3.5 Adenosquamous Carcinomas
1.4 Global mRNA Cancer Vaccines and Therapeutics Market by Application
1.4.1 Overview: Global mRNA Cancer Vaccines and Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Infectious Disease
1.4.3 Cancer
1.4.4 Others
1.5 Global mRNA Cancer Vaccines and Therapeutics Market Size & Forecast
1.6 Global mRNA Cancer Vaccines and Therapeutics Market Size and Forecast by Region
1.6.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Moderna Therapeutics
2.1.1 Moderna Therapeutics Details
2.1.2 Moderna Therapeutics Major Business
2.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.1.4 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Moderna Therapeutics Recent Developments and Future Plans
2.2 CureVac
2.2.1 CureVac Details
2.2.2 CureVac Major Business
2.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.2.4 CureVac mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CureVac Recent Developments and Future Plans
2.3 Translate Bio
2.3.1 Translate Bio Details
2.3.2 Translate Bio Major Business
2.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.3.4 Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Translate Bio Recent Developments and Future Plans
2.4 BioNTech
2.4.1 BioNTech Details
2.4.2 BioNTech Major Business
2.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.4.4 BioNTech mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 BioNTech Recent Developments and Future Plans
2.5 Sangamo Therapeutics
2.5.1 Sangamo Therapeutics Details
2.5.2 Sangamo Therapeutics Major Business
2.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.5.4 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sangamo Therapeutics Recent Developments and Future Plans
2.6 Argos Therapeutics
2.6.1 Argos Therapeutics Details
2.6.2 Argos Therapeutics Major Business
2.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.6.4 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Argos Therapeutics Recent Developments and Future Plans
2.7 In-Cell-Art
2.7.1 In-Cell-Art Details
2.7.2 In-Cell-Art Major Business
2.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.7.4 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 In-Cell-Art Recent Developments and Future Plans
2.8 eTheRNA
2.8.1 eTheRNA Details
2.8.2 eTheRNA Major Business
2.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.8.4 eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 eTheRNA Recent Developments and Future Plans
2.9 Ethris
2.9.1 Ethris Details
2.9.2 Ethris Major Business
2.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.9.4 Ethris mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Ethris Recent Developments and Future Plans
2.10 Tiba Biotechnology
2.10.1 Tiba Biotechnology Details
2.10.2 Tiba Biotechnology Major Business
2.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.10.4 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Tiba Biotechnology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global mRNA Cancer Vaccines and Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of mRNA Cancer Vaccines and Therapeutics by Company Revenue
3.2.2 Top 3 mRNA Cancer Vaccines and Therapeutics Players Market Share in 2023
3.2.3 Top 6 mRNA Cancer Vaccines and Therapeutics Players Market Share in 2023
3.3 mRNA Cancer Vaccines and Therapeutics Market: Overall Company Footprint Analysis
3.3.1 mRNA Cancer Vaccines and Therapeutics Market: Region Footprint
3.3.2 mRNA Cancer Vaccines and Therapeutics Market: Company Product Type Footprint
3.3.3 mRNA Cancer Vaccines and Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global mRNA Cancer Vaccines and Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2030)
6.2 North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2030)
6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country
6.3.1 North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country
7.3.1 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region
8.3.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2030)
9.2 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2030)
9.3 South America mRNA Cancer Vaccines and Therapeutics Market Size by Country
9.3.1 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country
10.3.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 mRNA Cancer Vaccines and Therapeutics Market Drivers
11.2 mRNA Cancer Vaccines and Therapeutics Market Restraints
11.3 mRNA Cancer Vaccines and Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 mRNA Cancer Vaccines and Therapeutics Industry Chain
12.2 mRNA Cancer Vaccines and Therapeutics Upstream Analysis
12.3 mRNA Cancer Vaccines and Therapeutics Midstream Analysis
12.4 mRNA Cancer Vaccines and Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of mRNA Cancer Vaccines and Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of mRNA Cancer Vaccines and Therapeutics by Type
1.3.1 Overview: Global mRNA Cancer Vaccines and Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Adeno Carcinomas
1.3.4 Mucinous Carcinomas
1.3.5 Adenosquamous Carcinomas
1.4 Global mRNA Cancer Vaccines and Therapeutics Market by Application
1.4.1 Overview: Global mRNA Cancer Vaccines and Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Infectious Disease
1.4.3 Cancer
1.4.4 Others
1.5 Global mRNA Cancer Vaccines and Therapeutics Market Size & Forecast
1.6 Global mRNA Cancer Vaccines and Therapeutics Market Size and Forecast by Region
1.6.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Moderna Therapeutics
2.1.1 Moderna Therapeutics Details
2.1.2 Moderna Therapeutics Major Business
2.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.1.4 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Moderna Therapeutics Recent Developments and Future Plans
2.2 CureVac
2.2.1 CureVac Details
2.2.2 CureVac Major Business
2.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.2.4 CureVac mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CureVac Recent Developments and Future Plans
2.3 Translate Bio
2.3.1 Translate Bio Details
2.3.2 Translate Bio Major Business
2.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.3.4 Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Translate Bio Recent Developments and Future Plans
2.4 BioNTech
2.4.1 BioNTech Details
2.4.2 BioNTech Major Business
2.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.4.4 BioNTech mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 BioNTech Recent Developments and Future Plans
2.5 Sangamo Therapeutics
2.5.1 Sangamo Therapeutics Details
2.5.2 Sangamo Therapeutics Major Business
2.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.5.4 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sangamo Therapeutics Recent Developments and Future Plans
2.6 Argos Therapeutics
2.6.1 Argos Therapeutics Details
2.6.2 Argos Therapeutics Major Business
2.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.6.4 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Argos Therapeutics Recent Developments and Future Plans
2.7 In-Cell-Art
2.7.1 In-Cell-Art Details
2.7.2 In-Cell-Art Major Business
2.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.7.4 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 In-Cell-Art Recent Developments and Future Plans
2.8 eTheRNA
2.8.1 eTheRNA Details
2.8.2 eTheRNA Major Business
2.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.8.4 eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 eTheRNA Recent Developments and Future Plans
2.9 Ethris
2.9.1 Ethris Details
2.9.2 Ethris Major Business
2.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.9.4 Ethris mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Ethris Recent Developments and Future Plans
2.10 Tiba Biotechnology
2.10.1 Tiba Biotechnology Details
2.10.2 Tiba Biotechnology Major Business
2.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product and Solutions
2.10.4 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Tiba Biotechnology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global mRNA Cancer Vaccines and Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of mRNA Cancer Vaccines and Therapeutics by Company Revenue
3.2.2 Top 3 mRNA Cancer Vaccines and Therapeutics Players Market Share in 2023
3.2.3 Top 6 mRNA Cancer Vaccines and Therapeutics Players Market Share in 2023
3.3 mRNA Cancer Vaccines and Therapeutics Market: Overall Company Footprint Analysis
3.3.1 mRNA Cancer Vaccines and Therapeutics Market: Region Footprint
3.3.2 mRNA Cancer Vaccines and Therapeutics Market: Company Product Type Footprint
3.3.3 mRNA Cancer Vaccines and Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global mRNA Cancer Vaccines and Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2030)
6.2 North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2030)
6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country
6.3.1 North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country
7.3.1 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region
8.3.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2030)
9.2 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2030)
9.3 South America mRNA Cancer Vaccines and Therapeutics Market Size by Country
9.3.1 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country
10.3.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 mRNA Cancer Vaccines and Therapeutics Market Drivers
11.2 mRNA Cancer Vaccines and Therapeutics Market Restraints
11.3 mRNA Cancer Vaccines and Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 mRNA Cancer Vaccines and Therapeutics Industry Chain
12.2 mRNA Cancer Vaccines and Therapeutics Upstream Analysis
12.3 mRNA Cancer Vaccines and Therapeutics Midstream Analysis
12.4 mRNA Cancer Vaccines and Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Moderna Therapeutics Company Information, Head Office, and Major Competitors
Table 6. Moderna Therapeutics Major Business
Table 7. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 8. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Moderna Therapeutics Recent Developments and Future Plans
Table 10. CureVac Company Information, Head Office, and Major Competitors
Table 11. CureVac Major Business
Table 12. CureVac mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 13. CureVac mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. CureVac Recent Developments and Future Plans
Table 15. Translate Bio Company Information, Head Office, and Major Competitors
Table 16. Translate Bio Major Business
Table 17. Translate Bio mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 18. Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Translate Bio Recent Developments and Future Plans
Table 20. BioNTech Company Information, Head Office, and Major Competitors
Table 21. BioNTech Major Business
Table 22. BioNTech mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 23. BioNTech mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. BioNTech Recent Developments and Future Plans
Table 25. Sangamo Therapeutics Company Information, Head Office, and Major Competitors
Table 26. Sangamo Therapeutics Major Business
Table 27. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 28. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Sangamo Therapeutics Recent Developments and Future Plans
Table 30. Argos Therapeutics Company Information, Head Office, and Major Competitors
Table 31. Argos Therapeutics Major Business
Table 32. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 33. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Argos Therapeutics Recent Developments and Future Plans
Table 35. In-Cell-Art Company Information, Head Office, and Major Competitors
Table 36. In-Cell-Art Major Business
Table 37. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 38. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. In-Cell-Art Recent Developments and Future Plans
Table 40. eTheRNA Company Information, Head Office, and Major Competitors
Table 41. eTheRNA Major Business
Table 42. eTheRNA mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 43. eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. eTheRNA Recent Developments and Future Plans
Table 45. Ethris Company Information, Head Office, and Major Competitors
Table 46. Ethris Major Business
Table 47. Ethris mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 48. Ethris mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Ethris Recent Developments and Future Plans
Table 50. Tiba Biotechnology Company Information, Head Office, and Major Competitors
Table 51. Tiba Biotechnology Major Business
Table 52. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 53. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Tiba Biotechnology Recent Developments and Future Plans
Table 55. Global mRNA Cancer Vaccines and Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 56. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Players (2019-2024)
Table 57. Breakdown of mRNA Cancer Vaccines and Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in mRNA Cancer Vaccines and Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key mRNA Cancer Vaccines and Therapeutics Players
Table 60. mRNA Cancer Vaccines and Therapeutics Market: Company Product Type Footprint
Table 61. mRNA Cancer Vaccines and Therapeutics Market: Company Product Application Footprint
Table 62. mRNA Cancer Vaccines and Therapeutics New Market Entrants and Barriers to Market Entry
Table 63. mRNA Cancer Vaccines and Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global mRNA Cancer Vaccines and Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Share by Type (2019-2024)
Table 66. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 67. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2024)
Table 68. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 69. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 99. mRNA Cancer Vaccines and Therapeutics Raw Material
Table 100. Key Suppliers of mRNA Cancer Vaccines and Therapeutics Raw Materials
Table 1. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Moderna Therapeutics Company Information, Head Office, and Major Competitors
Table 6. Moderna Therapeutics Major Business
Table 7. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 8. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Moderna Therapeutics Recent Developments and Future Plans
Table 10. CureVac Company Information, Head Office, and Major Competitors
Table 11. CureVac Major Business
Table 12. CureVac mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 13. CureVac mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. CureVac Recent Developments and Future Plans
Table 15. Translate Bio Company Information, Head Office, and Major Competitors
Table 16. Translate Bio Major Business
Table 17. Translate Bio mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 18. Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Translate Bio Recent Developments and Future Plans
Table 20. BioNTech Company Information, Head Office, and Major Competitors
Table 21. BioNTech Major Business
Table 22. BioNTech mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 23. BioNTech mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. BioNTech Recent Developments and Future Plans
Table 25. Sangamo Therapeutics Company Information, Head Office, and Major Competitors
Table 26. Sangamo Therapeutics Major Business
Table 27. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 28. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Sangamo Therapeutics Recent Developments and Future Plans
Table 30. Argos Therapeutics Company Information, Head Office, and Major Competitors
Table 31. Argos Therapeutics Major Business
Table 32. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 33. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Argos Therapeutics Recent Developments and Future Plans
Table 35. In-Cell-Art Company Information, Head Office, and Major Competitors
Table 36. In-Cell-Art Major Business
Table 37. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 38. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. In-Cell-Art Recent Developments and Future Plans
Table 40. eTheRNA Company Information, Head Office, and Major Competitors
Table 41. eTheRNA Major Business
Table 42. eTheRNA mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 43. eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. eTheRNA Recent Developments and Future Plans
Table 45. Ethris Company Information, Head Office, and Major Competitors
Table 46. Ethris Major Business
Table 47. Ethris mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 48. Ethris mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Ethris Recent Developments and Future Plans
Table 50. Tiba Biotechnology Company Information, Head Office, and Major Competitors
Table 51. Tiba Biotechnology Major Business
Table 52. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 53. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Tiba Biotechnology Recent Developments and Future Plans
Table 55. Global mRNA Cancer Vaccines and Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 56. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Players (2019-2024)
Table 57. Breakdown of mRNA Cancer Vaccines and Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in mRNA Cancer Vaccines and Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key mRNA Cancer Vaccines and Therapeutics Players
Table 60. mRNA Cancer Vaccines and Therapeutics Market: Company Product Type Footprint
Table 61. mRNA Cancer Vaccines and Therapeutics Market: Company Product Application Footprint
Table 62. mRNA Cancer Vaccines and Therapeutics New Market Entrants and Barriers to Market Entry
Table 63. mRNA Cancer Vaccines and Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global mRNA Cancer Vaccines and Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Share by Type (2019-2024)
Table 66. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 67. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2024)
Table 68. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 69. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 99. mRNA Cancer Vaccines and Therapeutics Raw Material
Table 100. Key Suppliers of mRNA Cancer Vaccines and Therapeutics Raw Materials
LIST OF FIGURES
Figure 1. mRNA Cancer Vaccines and Therapeutics Picture
Figure 2. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Adeno Carcinomas
Figure 5. Mucinous Carcinomas
Figure 6. Adenosquamous Carcinomas
Figure 7. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application in 2023
Figure 9. Infectious Disease Picture
Figure 10. Cancer Picture
Figure 11. Others Picture
Figure 12. Global mRNA Cancer Vaccines and Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global mRNA Cancer Vaccines and Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market mRNA Cancer Vaccines and Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 16. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Region in 2023
Figure 17. North America mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 20. South America mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 22. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Players in 2023
Figure 23. mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players mRNA Cancer Vaccines and Therapeutics Market Share in 2023
Figure 25. Global Top 6 Players mRNA Cancer Vaccines and Therapeutics Market Share in 2023
Figure 26. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Share by Type (2019-2024)
Figure 27. Global mRNA Cancer Vaccines and Therapeutics Market Share Forecast by Type (2025-2030)
Figure 28. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Share by Application (2019-2024)
Figure 29. Global mRNA Cancer Vaccines and Therapeutics Market Share Forecast by Application (2025-2030)
Figure 30. North America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 31. North America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 32. North America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 33. United States mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 40. France mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 47. China mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 50. India mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 53. South America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 54. South America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 55. South America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 64. mRNA Cancer Vaccines and Therapeutics Market Drivers
Figure 65. mRNA Cancer Vaccines and Therapeutics Market Restraints
Figure 66. mRNA Cancer Vaccines and Therapeutics Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of mRNA Cancer Vaccines and Therapeutics in 2023
Figure 69. Manufacturing Process Analysis of mRNA Cancer Vaccines and Therapeutics
Figure 70. mRNA Cancer Vaccines and Therapeutics Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. mRNA Cancer Vaccines and Therapeutics Picture
Figure 2. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Adeno Carcinomas
Figure 5. Mucinous Carcinomas
Figure 6. Adenosquamous Carcinomas
Figure 7. Global mRNA Cancer Vaccines and Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application in 2023
Figure 9. Infectious Disease Picture
Figure 10. Cancer Picture
Figure 11. Others Picture
Figure 12. Global mRNA Cancer Vaccines and Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global mRNA Cancer Vaccines and Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market mRNA Cancer Vaccines and Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 16. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Region in 2023
Figure 17. North America mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 20. South America mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 22. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Players in 2023
Figure 23. mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players mRNA Cancer Vaccines and Therapeutics Market Share in 2023
Figure 25. Global Top 6 Players mRNA Cancer Vaccines and Therapeutics Market Share in 2023
Figure 26. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Share by Type (2019-2024)
Figure 27. Global mRNA Cancer Vaccines and Therapeutics Market Share Forecast by Type (2025-2030)
Figure 28. Global mRNA Cancer Vaccines and Therapeutics Consumption Value Share by Application (2019-2024)
Figure 29. Global mRNA Cancer Vaccines and Therapeutics Market Share Forecast by Application (2025-2030)
Figure 30. North America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 31. North America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 32. North America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 33. United States mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 40. France mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 47. China mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 50. India mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 53. South America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 54. South America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 55. South America mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE mRNA Cancer Vaccines and Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 64. mRNA Cancer Vaccines and Therapeutics Market Drivers
Figure 65. mRNA Cancer Vaccines and Therapeutics Market Restraints
Figure 66. mRNA Cancer Vaccines and Therapeutics Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of mRNA Cancer Vaccines and Therapeutics in 2023
Figure 69. Manufacturing Process Analysis of mRNA Cancer Vaccines and Therapeutics
Figure 70. mRNA Cancer Vaccines and Therapeutics Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
